Department Resources
(Password Required)
Purpose
This is a new research area that grew out of Dr. Imig’s interest
in neural mechanisms of tinnitus and Dr. Durham’s expertise
in anatomical methods to evaluate spontaneous activity in the CNS.
These experiments, which utilize a rat model of tinnitus caused
by noise exposure, have revealed frequency-specific changes in
CNS spontaneous activity that provide clues to the neural basis
of tinnitus. Funding for these experiments has recently been acquired
from the Tinnitus Research Consortium, and an NIH R01 application
is also in preparation.
Support
Tinnitus Research Consortium: A Neural Correlate of
Tinnitus
Thomas J. Imig, PhD, Principal Investigator
Dianne Durham, PhD, Co-Investigator
Publications
Abstracts
Purpose:
These experiments are done by Dr. Durham and Dr. Debara Tucci at
Duke University, a collaboration which began in 1995. The goal
of this project is to examine the effects of various degrees
of hearing loss on central auditory anatomy and physiology in
the developing gerbil. In 2002 Dr. Tucci successfully received
R01 funding for these studies, which have been expanded to explore
the effects of reversible hearing loss in the gerbil. The experiments
done in collaboration with Dr. Durham are funded by a subcontract
to KUMC.
Support:
NIDCD R01 DC005416 Central Auditory System Effects of Auditory
Deprivation
Debara Tucci, MD, Principal Investigator
Dianne Durham, PhD, Co-Investigator
Publications
Hutson KA, Durham D, Imig T, Tucci DL. Consequences of unilateral hearing loss: Cortical adjustment to unilateral deprivation. Hear Res. 2008 Mar;237(1-2):19-31. Epub 2007 Dec 28.
Hutson KA, Durham D, Tucci DL. Consequences of unilateral hearing loss: time dependent regulation of protein synthesis in auditory brainstem nuclei. Hear Res. 2007 Nov;233(1-2):124-34. Epub 2007 Aug 30.
Abstracts
Hutson, K., Durham, D., Tucci , D.L. Protein synthesis in central auditory system nuclei following conductive hearing loss. Assoc Research Otolaryngol 28: 1181, 2005.
Purpose
These experiments explore changes in the central nervous system
that occur following either irreversible removal of cochlear
input (cochlear ablation) or during the ototoxic loss and regeneration
of cochlear hair cells. These questions are addressed in hatchling
animals as well as in adult birds that undergo progressive, age-related
cochlear degeneration.
Support
NIH (NIDCD) R01 DC01589 Cellular Processes of Central Auditory
Neuronal Death
Dianne Durham, Ph.D., P.I.; Douglas A Girod, M.D. Collaborator
Publications
Smittkamp, S.E., Durham, D. Effect of cochlear integrity on cochlear nucleus neuron glucose metabolism in aged adult broiler chickens. Hearing Research, 202:209-221, 2005.
Smittkamp, S.E., Girod, D.A., Durham, D. Role of cochlear integrity in cochlear nucleus neuron activity and number after cochlea removal in aging broiler chickens. Hearing Research, 204:48-59, 2005.
Purpose
The purpose of this pilot study is to investigate the effect of
vagal nerve stimulation (VNS) on a rat model of tinnitus. VNS
stimulation may reduce the alteration of spontaneous activity
caused by noise trauma and thus warrants further study as a potential
tinnitus therapy. Additionally, studies will involve evaluation
of the effect of VNS on a rat tinnitus model of the primary auditory
cortex.
Support
Advanced Bionics
Publications
Ursick, J., Staecker, H. An Overview of Animal Models of Tinnitus. B-ENT. 2007;3 Suppl 7:23-5.
Abstracts
Ursick, J., Durham, D., Staecker, H., Lefebvre, P., Schoenen, J., Imig, T. Effect of vagal nerve stimulation on a rat tinnitus model. Presentation at the Association for Research in Otolaryngology midwinter meeting. February 2007.
Purpose
This series of studies aims to develop a molecular solution for
bilateral vestbibular hypofunction (BVH). The success of a molecular
therapy program for inner ear disease depends on our ability
to correctly target a patient population. This study aims to
translate recent key findings from gene research into a therapy
for patients with an unmet medical need. The gene controlling
development of hearing and balance sensory cells will be tested
for its ability to restore balance function in models that prepare
moving this molecular therapeutic into clinical studies.
Support
NIH (NIDCD) R01 DC008424
Hinrich Staecker P.I.
Purpose
There are three prospective trials currently enrolling patients
within the Department of Otolaryngology-Head and Neck Surgery
and the University of Kansas Medical Center. All three of these
trials aim to provide patients with the most advanced technology
available for hearing improvement. Patients with ski-slope hearing
loss and poor speech discrimination are potentially eligible
for the Duet device. Patients with conductive and mixed hearing
loss are potentially eligible for the Vibrant Soundbridge. Finally,
patients interested in a totally implantable hearing device are
potentially eligible for the Otologics trial.
Support
MED-EL
Otologics, LLC
Posters
Purpose
The Pediatric Division of the Department offers two prospective
safety and efficacy trials for patients. Numerous patients enter
our practice with a diagnosis of chronic sinusitis. These patients
often have been treated medically with multiple courses of antibiotics
and yet they remain symptomatic. This double blind placebo controlled
trial aims to evaluate the safety and efficacy of daily nasal
irrigations with and without gentamycin. Additionally, another
population of patients receives a referral to the clinic for
hoarseness. This double blind placebo controlled trial aims to
compare the efficacy of dietary control alone and dietary control
plus a proton pump inhibitor for the improvement of hoarseness
symptoms. Finally, parents and patients are offered several surgical
options within otolaryngology, outcomes and quality of life of
significant factors in understanding the effectiveness of these
treatments and evaluating these factors is key to providing the
best care for our patients.
Support
TAP Pharmaceuticals, Inc.
KUMC Otolaryngology Department Research Endowment
Publications/Presentations
Purpose
The head and neck cancer patients in our practice are offered a
number of surgical and non-surgical options for the treatment
of their head and neck cancer. These therapies are constantly
reviewed for the development of new options and the evaluation
of the quality of every outcome. Prospective and retrospective
clinical research projects are numerous and ongoing.
Support
American Academy of Otolaryngology Head and
Neck Society
An Investigator-initiated, Multicenter, Randomized, Double-Blind
Placebo-Controlled Design Study to Assess the Effectiveness of
Cevimeline to Improve Oral Health in Patients with Xerostomia Secondary
to Radiation Therapy for Treatment of Head and Neck Squamous Cell
Carcinoma -- study details at ClinicalTrials.gov
Viventia Biotech, Inc.
A Phase II, Open-Label Study to Evaluate the Safety, Tolerability,
and Pharmacokinetic Profile of ProxinumTM in Patients with Recurrent
Squamous Cell Carcinoma of the Head and Neck Who Have Received
at Least One Prior Anti-Cancer Treatment Regimen for Recurrent
Disease
KUMC Otolaryngology Department Research Endowment
Publications/Presentations
Support
KUMC Otolaryngology Department Research Endowment
Department of Otolaryngology; North Shore-Long Island Jewish Health System Long Island Jewish Medical Center Campus
Publications/Presenations
